Home > Insider Trading > Filing (0001415889-24-005476)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1649094	Vaxcyte Inc.	PCVX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1258693	Grant Pickering	C/O Vaxcyte, Inc. 825 Industrial Road, Ste. 300 San Carlos CA 94070	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-02-23	15,000	$1.79	390,814	No	4	M	Direct
Common Stock	Disposition	2024-02-23	2,356	$75.15	388,458	No	4	S	Direct
Common Stock	Disposition	2024-02-23	6,980	$75.96	381,478	No	4	S	Direct
Common Stock	Disposition	2024-02-23	5,545	$76.95	375,933	No	4	S	Direct
Common Stock	Disposition	2024-02-23	119	$77.56	375,814	No	4	S	Direct
Common Stock	Acquisiton	2024-02-26	30,000	$1.79	405,814	No	4	M	Direct
Common Stock	Disposition	2024-02-26	30,000	$79.03	375,814	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2024-02-23	15,000	$0.00	15,000	$1.79
Common Stock	Stock Option (Right to Buy)	Disposition	2024-02-26	30,000	$0.00	30,000	$1.79

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
60,225		2027-05-17	No	4	M	Direct
30,225		2027-05-17	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	149,978	Indirect	By Children's Trust
Common Stock	149,978	Indirect	By Children's Trust

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023.
The price reported is a weighted-average price. The shares were sold at prices ranging from $74.45 to $75.52. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $75.545 to $76.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $76.54 to $77.475. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The price reported is a weighted-average price. The shares were sold at prices ranging from $79.03 to $79.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
Shares are held directly by a trust for the benefit of the Reporting Person's son.
Stock Option is fully vested and exercisable.